Elevated homocysteine levels in mothers with neural tube defects: a systematic review and meta-analysis

References

• Tuncbilek E, Boduroglu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distribution and risk factors. Turk J Pediatr 1999;41:299–305
   PubMed Web of Science ®Google Scholar
• Castilla EE, Orioli IM. Epidemiology of neural tube defects in South America. Am J Med Genet 1985;22:695–702
   PubMed Web of Science ®Google Scholar
• Busby A, Abramsky L, Dolk H, et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 2005;20:393–402
   PubMed Web of Science ®Google Scholar
• Laurence KM, James N, Miller MH, et al. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed.) 1981;282:1509
   PubMed Web of Science ®Google Scholar
• Group VSR. Prevention of neural tube defects: results of the medical research council vitamin study. MRC vitamin study research group. Lancet 1991;338:131–7
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Dudas I, Paput L, et al. Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab 2011;58:263–71
   PubMed Web of Science ®Google Scholar
• China Ministry of Health. Report of birth defects prevention in China; 2012
   Google Scholar
• Kim MW, Ahn KH, Ryu KJ, et al. Preventive effects of folic acid supplementation on adverse maternal and fetal outcomes. PLoS One 2014;9:e97273
   PubMed Web of Science ®Google Scholar
• Wen SW, Walker M. An exploration of health effects of folic acid in pregnancy beyond reducing neural tube defects. J Obstet Gynaecol Can 2005;27:13–9
   PubMedGoogle Scholar
• van der Put NM, van Straaten HW, Trijbels FJ, et al. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 2001;226:243–70
   PubMed Web of Science ®Google Scholar
• Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228–37
   PubMed Web of Science ®Google Scholar
• Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 1996;93:15227–32
   PubMed Web of Science ®Google Scholar
• Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med 1991;324:199–200
   PubMed Web of Science ®Google Scholar
• Kirke PN, Mills JL, Scott JM. Homocysteine metabolism in pregnancies complicated by neural tube defects. Nutrition 1997;13:994–5
   PubMed Web of Science ®Google Scholar
• Ueland PM, Vollset SE. Homocysteine and folate in pregnancy. Clin Chem 2004;50:1293–5
   PubMed Web of Science ®Google Scholar
• Morrison K, Edwards YH, Lynch SA, et al. Methionine synthase and neural tube defects. J Med Genet 1997;34:958
   PubMed Web of Science ®Google Scholar
• Richter B, Stegmann K, Roper B, et al. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 2001;46:105–9
   PubMed Web of Science ®Google Scholar
• Ceyhan ST, Beyan C, Atay V, et al. Serum vitamin B12 and homocysteine levels in pregnant women with neural tube defect. Gynecol Endocrinol 2010;26:578–81
   PubMed Web of Science ®Google Scholar
• Gaber KR, Farag MK, Soliman SE, et al. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab 2007;53:69–75
   PubMed Web of Science ®Google Scholar
• Murphy MM, Scott JM, Arija V, et al. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004;50:1406–12
   PubMed Web of Science ®Google Scholar
• Walker MC, Smith GN, Perkins SL, et al. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999;180:660–4
   PubMed Web of Science ®Google Scholar
• Zhang HY, Luo GA, Liang QL, et al. Neural tube defects and disturbed maternal folate- and homocysteine-mediated one-carbon metabolism. Exp Neurol 2008;212:515–21
   PubMed Web of Science ®Google Scholar
• Mills JL, Mcpartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995;345:149–51
   PubMed Web of Science ®Google Scholar
• Wang F, Wang J, Guo J, et al. PCMT1 gene polymorphisms, maternal folate metabolism, and neural tube defects: a case-control study in a population with relatively low folate intake. Genes Nutr 2013;8:581–7
   PubMed Web of Science ®Google Scholar
• Candito M, Rivet R, Herbeth B, et al. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet A 2008;146A:1128–33
   PubMed Web of Science ®Google Scholar
• Steegers-Theunissen RP, Boers GH, Blom HJ, et al. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 1995;172:1436–41
   PubMed Web of Science ®Google Scholar
• Ubbink JB, Christianson A, Bester MJ, et al. Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metab Clin Exp 1999;48:269–74
   PubMed Web of Science ®Google Scholar
• Arbor L, Christensen B, Delormier T, et al. Spina bifida, folate metabolism, and dietary folate intake in a Northern Canadian aboriginal population. Int J Circumpolar Health 2002;61:341–51
   PubMedGoogle Scholar
• Felix TM, Leistner S, Giugliani R. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 2004;70:459–63
   PubMed Web of Science ®Google Scholar
• Lacasana M, Blanco-Munoz J, Borja-Aburto VH, et al. Effect on risk of anencephaly of gene-nutrient interactions between methylenetetrahydrofolate reductase C677T polymorphism and maternal folate, vitamin B12 and homocysteine profile. Public Health Nutr 2012;15:1419–28
   PubMed Web of Science ®Google Scholar
• Perez AB, D'Almeida V, Vergani N, et al. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet A 2003;119A:20–5
   PubMed Web of Science ®Google Scholar
• Ratan SK, Rattan KN, Pandey RM, et al. Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls. Pediatr Surg Int 2008;24:803–8
   PubMed Web of Science ®Google Scholar
• Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metab Clin Exp 1994;43:1475–80
   PubMed Web of Science ®Google Scholar
• Higgins J, White IR, Anzures Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med 2008;27:6072–92
   PubMed Web of Science ®Google Scholar
• Godbole K, Gayathri P, Ghule S, et al. Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. Birth Defects Res A Clin Mol Teratol 2011;91:848–56
   PubMed Web of Science ®Google Scholar
• Felkner M, Suarez L, Canfield MA, et al. Maternal serum homocysteine and risk for neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol 2009;85:574–81
   PubMed Web of Science ®Google Scholar
• Cadenas-Benitez NM, Yanes-Sosa F, Gonzalez-Meneses A, et al. Association of neural tube defects in children of mothers with MTHFR 677TT genotype and abnormal carbohydrate metabolism risk: a case-control study. Genet Mol Res 2014;13:2200–7
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
   PubMedGoogle Scholar
• Berti C, Fekete K, Dullemeijer C, et al. Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: a meta-analysis. J Nutr Metab 2012;2012:470656
   PubMedGoogle Scholar
• Ubbink JB. Is an elevated circulating maternal homocysteine concentration a risk factor for neural tube defects? Nutr Rev 1995;53:173–5
   PubMed Web of Science ®Google Scholar
• Zhang T, Xin R, Gu X, et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr 2009;12:680–6
   PubMed Web of Science ®Google Scholar
• Gu Q, Li Y, Cui ZL, et al. Homocysteine, folate, vitamin B12 and B6 in mothers of children with neural tube defects in Xinjiang, China. Acta Paediatr 2012;101:e486–90
   PubMed Web of Science ®Google Scholar
• Tang KF, Li YL, Wang HY. Quantitative assessment of maternal biomarkers related to one-carbon metabolism and neural tube defects. Sci Rep 2015;5:8510
   PubMed Web of Science ®Google Scholar